Oral Corticosteroid
Pregnancy: Compatible for significant indications — crosses placenta minimally (prednisolone metabolised to inactive form by placenta); monitor for neonatal adrenal insufficiency
Prednisolone (Oral — General Medicine)
Brand names: Prednisolone (generic)
Adult dose
Dose: Inflammatory/autoimmune conditions: 30–60 mg OD initially (or as per condition-specific protocol). Reduce by 5–10 mg every 1–2 weeks when improving. Maintenance: lowest effective dose.
Route: Oral
Frequency: Once daily in the morning (with food)
Max: 60–80 mg/day (acute high-dose); 5–15 mg/day maintenance
Always prescribe 'Prednisolone' — do not use 'steroids' alone on prescriptions. Prescribe with gastric protection (PPI) if at risk of peptic ulcer. Bone protection if >3 months use (bisphosphonate).
Paediatric dose
Dose: 1 mg/kg
Route: Oral
Frequency: OD–BD
Max: 60 mg/day
Concentration: 1 mg/mL or 5 mg/mL oral solution mg/ml
Asthma exacerbation: 1–2 mg/kg/day (max 40 mg) for 3–5 days. Nephrotic syndrome: 60 mg/m²/day or 2 mg/kg/day.
Dose adjustments
Renal
No dose adjustment required; may cause fluid retention in renal failure
Hepatic
Caution — increased risk of infection; active hepatitis is a relative contraindication without antiviral cover
Paediatric weight-based calculator
Asthma exacerbation: 1–2 mg/kg/day (max 40 mg) for 3–5 days. Nephrotic syndrome: 60 mg/m²/day or 2 mg/kg/day.
Clinical pearls
- Sick day rules: never suddenly stop after >3 weeks use — adrenal suppression. Reduce gradually.
- Bone protection: start bisphosphonate (alendronate) + calcium/vitamin D if course >3 months anticipated (FRAX-guided)
- Steroid card: carry blue steroid card during any course >3 weeks or doses equivalent to >6 mg prednisolone/day
- Hyperglycaemia: check random blood glucose after starting; may unmask T2DM or require insulin adjustment
Contraindications
- Active systemic fungal infection (without antifungal cover)
- Live vaccines contraindicated with immunosuppressive doses
Side effects
- Hyperglycaemia (steroid-induced diabetes)
- Hypertension
- Weight gain/moon face/truncal obesity
- Osteoporosis (long-term)
- Adrenal suppression
- Psychiatric effects (mania, depression, psychosis)
- GI bleeding
- Cataracts (long-term)
- Increased infection susceptibility
- Growth suppression (children)
Interactions
- NSAIDs — additive GI bleeding risk
- Anticoagulants — variable effect on INR (monitor)
- Rifampicin — reduces prednisolone levels
- Live vaccines — contraindicated
- ACEi — hyperkalaemia risk
- Antidiabetics — higher doses required
Monitoring
- Blood glucose
- Blood pressure
- Weight
- Bone density (long-term — DEXA)
- Eye pressure (prolonged high-dose — glaucoma risk)
- Signs of infection
- Growth in children
Reference: BNFc; BNF; NICE guidance on glucocorticoid use; RCP Steroid Emergency Card guidance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Rapid Emergency Medicine Score (REMS) · Severity Scoring
- Steroid Dose Equivalence · Medications
- HOSPITAL Score for 30-Day Readmission · Prognosis
- Number Needed to Treat (NNT) / Number Needed to Harm (NNH) · Evidence-Based Medicine
- Maddrey Discriminant Function (Alcoholic Hepatitis) · Alcoholic Liver Disease